Voya Financial Advisors’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.04M | Sell |
38,414
-1,094
| -3% | -$29.1K | 0.1% | 87 |
|
|
2025
Q4 | $988K | Sell |
39,508
-1,448
| -4% | -$36.5K | 0.09% | 100 |
|
|
2025
Q3 | $977K | Sell |
40,956
-4,825
| -11% | -$119K | 0.09% | 97 |
|
|
2025
Q2 | $1.11M | Buy |
45,781
+2,790
| +6% | +$65.1K | 0.11% | 92 |
|
|
2025
Q1 | $1.08M | Buy |
42,991
+1,703
| +4% | +$44.6K | 0.12% | 88 |
|
|
2024
Q4 | $1.09M | Buy |
41,288
+1,841
| +5% | +$49.9K | 0.12% | 84 |
|
|
2024
Q3 | $1.15M | Buy |
39,447
+704
| +2% | +$20.5K | 0.12% | 81 |
|
|
2024
Q2 | $1.08M | Buy |
38,743
+894
| +2% | +$24.6K | 0.12% | 79 |
|
|
2024
Q1 | $1.05M | Buy |
37,849
+3,027
| +9% | +$84K | 0.12% | 77 |
|
|
2023
Q4 | $1M | Buy |
34,822
+361
| +1% | +$10.9K | 0.12% | 77 |
|
|
2023
Q3 | $1.11M | Buy |
34,461
+13,095
| +61% | +$463K | 0.14% | 59 |
|
|
2023
Q2 | $772K | Buy |
21,366
+1,747
| +9% | +$68K | 0.09% | 97 |
|
|
2023
Q1 | $792K | Buy |
19,619
+533
| +3% | +$23K | 0.1% | 97 |
|
|
2022
Q4 | $980K | Sell |
19,086
-1,210
| -6% | -$58K | 0.13% | 78 |
|
|
2022
Q3 | $896K | Buy |
20,296
+882
| +5% | +$42.9K | 0.12% | 92 |
|
|
2022
Q2 | $989K | Buy |
19,414
+1,203
| +7% | +$61.3K | 0.12% | 82 |
|
|
2022
Q1 | $955K | Buy |
18,211
+230
| +1% | +$11.9K | 0.11% | 93 |
|
|
2021
Q4 | $1.05M | Sell |
17,981
-14,604
| -45% | -$724K | 0.12% | 88 |
|
|
2021
Q3 | $1.42M | Sell |
32,585
-4,326
| -12% | -$192K | 0.17% | 55 |
|
|
2021
Q2 | $1.44M | Sell |
36,911
-197,357
| -84% | -$7.67M | 0.19% | 51 |
|
|
2021
Q1 | $8.46M | Buy |
234,268
+6,531
| +3% | +$232K | 0.33% | 45 |
|
|
2020
Q4 | $8.37M | Sell |
227,737
-10,698
| -4% | -$392K | 0.36% | 39 |
|
|
2020
Q3 | $8.18M | Sell |
238,435
-16,066
| -6% | -$563K | 0.41% | 40 |
|
|
2020
Q2 | $7.88M | Buy |
254,501
+4,734
| +2% | +$161K | 0.41% | 41 |
|
|
2020
Q1 | $7.74M | Sell |
249,767
-14,256
| -5% | -$486K | 0.43% | 39 |
|
|
2019
Q4 | $9.75M | Buy |
264,023
+24,135
| +10% | +$860K | 0.48% | 39 |
|
|
2019
Q3 | $8.24M | Buy |
239,888
+44,550
| +23% | +$1.62M | 0.44% | 44 |
|
|
2019
Q2 | $8.05M | Buy |
195,338
+12,417
| +7% | +$493K | 0.43% | 47 |
|
|
2019
Q1 | $7.34M | Buy |
182,921
+8,796
| +5% | +$352K | 0.43% | 50 |
|
|
2018
Q4 | $7.1M | Sell |
174,125
-1,486
| -0.8% | -$61.7K | 0.47% | 47 |
|
|
2018
Q3 | $7.31M | Buy |
175,611
+11,287
| +7% | +$435K | 0.43% | 44 |
|
|
2018
Q2 | $5.67M | Sell |
164,324
-2,890
| -2% | -$98.8K | 0.37% | 54 |
|
|
2018
Q1 | $5.6M | Sell |
167,214
-10,994
| -6% | -$378K | 0.37% | 56 |
|
|
2017
Q4 | $6.15M | Sell |
178,208
-16,277
| -8% | -$555K | 0.4% | 53 |
|
|
2017
Q3 | $6.57M | Sell |
194,485
-223
| -0.1% | -$7.17K | 0.44% | 46 |
|
|
2017
Q2 | $6.21M | Buy |
194,708
+10,330
| +6% | +$326K | 0.44% | 47 |
|
|
2017
Q1 | $6M | Buy |
184,378
+32,806
| +22% | +$1.03M | 0.47% | 43 |
|
|
2016
Q4 | $4.67M | Buy |
151,572
+38,593
| +34% | +$1.18M | 0.41% | 50 |
|
|
2016
Q3 | $3.57M | Buy |
112,979
+54,093
| +92% | +$1.81M | 0.36% | 55 |
|
|
2016
Q2 | $1.96M | Buy |
58,886
+4,800
| +9% | +$153K | 0.23% | 84 |
|
|
2016
Q1 | $1.54M | Buy |
54,086
+7,492
| +16% | +$214K | 0.22% | 89 |
|
|
2015
Q4 | $1.45M | Buy |
46,594
+5,230
| +13% | +$165K | 0.21% | 82 |
|
|
2015
Q3 | $1.22M | Buy |
41,364
+52
| +0.1% | +$1.67K | 0.22% | 82 |
|
|
2015
Q2 | $1.32M | Buy |
41,312
+1,646
| +4% | +$53.6K | 0.23% | 81 |
|
|
2015
Q1 | $1.32M | Buy |
+39,666
| New | +$1.26M | 0.26% | 91 |
|
Other funds holding PFE
VCM
VPM
Voya Financial Advisors's PFE Position: Q1 2026 in Review
Voya Financial Advisors reduced its Pfizer (PFE) stake by 2.8% in Q1 2026, selling an estimated $29.1K and leaving 38,414 shares worth $1.04M. The position accounts for 0.1% of the portfolio, ranked #87.
Voya Financial Advisors first reported a position in PFE in Q1 2015 and has held it in 45 quarters since. The position peaked at $9.75M in Q4 2019. 2,939 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Voya Financial Advisors held 38,414 shares of Pfizer worth $1.04M as of Q1 2026.
- Voya Financial Advisors sold 1,094 Pfizer shares in Q1 2026, an estimated $29.1K.
- Pfizer made up 0.1% of Voya Financial Advisors's portfolio in Q1 2026, its #87 holding.
- Voya Financial Advisors first reported a position in Pfizer in Q1 2015 and has held it in 45 quarters since.
- Voya Financial Advisors's Pfizer position peaked at $9.75M in Q4 2019.
- 2,939 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Voya Financial Advisors's 13F filing for Q1 2026, filed 12 May 2026.